These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16985043)

  • 1. Mesothelin is shed from tumor cells.
    Ho M; Onda M; Wang QC; Hassan R; Pastan I; Lively MO
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1751. PubMed ID: 16985043
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesothelin variant 1 is released from tumor cells as a diagnostic marker.
    Hellstrom I; Raycraft J; Kanan S; Sardesai NY; Verch T; Yang Y; Hellstrom KE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1014-20. PubMed ID: 16702385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
    Scholler N; Fu N; Yang Y; Ye Z; Goodman GE; Hellström KE; Hellström I
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11531-6. PubMed ID: 10500211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelin in serum.
    Hellstrom I
    Biochem Biophys Res Commun; 2008 Nov; 376(3):629; author reply 630. PubMed ID: 18789894
    [No Abstract]   [Full Text] [Related]  

  • 5. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
    Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
    Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble mesothelin related protein in mesothelioma.
    Creaney J; Christansen H; Lake R; Musk AB; de Klerk N; Robinson BW
    J Thorac Oncol; 2006 Feb; 1(2):172-4. PubMed ID: 17409849
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.
    Hellstrom I; Hellstrom KE
    Adv Exp Med Biol; 2008; 622():15-21. PubMed ID: 18546615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.
    Hassan R; Remaley AT; Sampson ML; Zhang J; Cox DD; Pingpank J; Alexander R; Willingham M; Pastan I; Onda M
    Clin Cancer Res; 2006 Jan; 12(2):447-53. PubMed ID: 16428485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New diagnostic markers for malignant pleural mesothelioma].
    Grigoriu BD; Grégoire M; Chahine B; Scherpereel A
    Bull Cancer; 2008 Feb; 95(2):177-84. PubMed ID: 18304902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor.
    Huang CY; Cheng WF; Lee CN; Su YN; Chien SC; Tzeng YL; Hsieh CY; Chen CA
    Anticancer Res; 2006; 26(6C):4721-8. PubMed ID: 17214332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
    Creaney J; van Bruggen I; Hof M; Segal A; Musk AW; de Klerk N; Horick N; Skates SJ; Robinson BW
    Chest; 2007 Oct; 132(4):1239-46. PubMed ID: 17646232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.
    Creaney J; Yeoman D; Demelker Y; Segal A; Musk AW; Skates SJ; Robinson BW
    J Thorac Oncol; 2008 Aug; 3(8):851-7. PubMed ID: 18670302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.
    Creaney J; Olsen NJ; Brims F; Dick IM; Musk AW; de Klerk NH; Skates SJ; Robinson BW
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2238-46. PubMed ID: 20651076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients.
    Hellstrom I; Friedman E; Verch T; Yang Y; Korach J; Jaffar J; Swisher E; Zhang B; Ben-Baruch G; Tan MC; Goedegebuure P; Hellstrom KE
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1520-6. PubMed ID: 18559570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
    Gubbels JA; Belisle J; Onda M; Rancourt C; Migneault M; Ho M; Bera TK; Connor J; Sathyanarayana BK; Lee B; Pastan I; Patankar MS
    Mol Cancer; 2006 Oct; 5(1):50. PubMed ID: 17067392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic biomarkers of malignant pleural mesothelioma].
    Rodríguez Portal JA
    Med Clin (Barc); 2009 Oct; 133(12):464-6. PubMed ID: 19748640
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of human mesothelin transcripts in ovarian and pancreatic cancer.
    Muminova ZE; Strong TV; Shaw DR
    BMC Cancer; 2004 May; 4():19. PubMed ID: 15140265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis.
    Luo L; Shi HZ; Liang QL; Jiang J; Qin SM; Deng JM
    Respir Med; 2010 Jan; 104(1):149-56. PubMed ID: 19945835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.